Plerixafor decreased the frequency of LAG-3+ CD4+ T cells in septic mice. by Kimberly M. Ramonell (4678906)

“…N = 3–5 mice/group. Representative of 3 independent experiments with a total of 12 mice/group.…”

Descriptive statistics†. by Raimundo Atal (18272064)

“…Respondents were asked basic socioeconomic questions and a version of the EQ-5D-5L questionnaire that was used to calculate the evolution of HRQoLs. …”

Robustness of results. by Raimundo Atal (18272064)

“…Respondents were asked basic socioeconomic questions and a version of the EQ-5D-5L questionnaire that was used to calculate the evolution of HRQoLs. …”

Chronic hyperoxia decreases relaxant response to acetylcholine in intrapulmonary arteries of newborn rats. by Eric Dumas de la Roque (3779935)

“…<p>(A) Arterial relaxant response to acetylcholine was significantly decreased by hyperoxia (<i>n</i> = 8 vessels from 3 animals) compared with normoxia (<i>n</i> = 15 vessels from 5 animals). …”

Decreased immunofluorescence signals for the CAMs at the synapses in cultured afadin-deficient hippocampal neurons. by Daisaku Toyoshima (528270)

Table_1_Changes in Vitamin A Levels and the Effect of Early Vitamin A Supplementation on Vitamin A Levels in Infants Throughout the First 6 Months of Life: A Prospective Cohort Stu... by Huan Liu (281351)

“…From birth to 6 months, the percentage of infants with a VA level <0.70 μmol/L decreased from 88.6 to 19.5%. …”

Demographics and baseline characteristics of the safety population. by Rahsan Erdem (11726357)

Subjects:

iOWH032 inhibits cholera toxin-induced secretion in a mouse closed-loop model. by Rahsan Erdem (11726357)

Subjects:

Grading of stool consistency and diarrhea severity. by Rahsan Erdem (11726357)

Subjects:

Secondary efficacy endpoints for the modified intent-to-treat population. by Rahsan Erdem (11726357)

Subjects:

Study drug–related treatment-emergent adverse events by system organ class and preferred term in the safety population. by Rahsan Erdem (11726357)

Subjects:

Source data for Fig 1. by Rahsan Erdem (11726357)

Subjects:

Diarrheal stool output rate overall and by blood type status in the modified intent-to-treat population. by Rahsan Erdem (11726357)

Subjects:

Source data for S1 and S2 Figs. by Rahsan Erdem (11726357)

Subjects:

Source data for Fig 2. by Rahsan Erdem (11726357)

Subjects:

Consolidated Standards for Reporting of Trials flow diagram. by Rahsan Erdem (11726357)

Subjects:

iOWH032 inhibits cholera toxin-induced fecal output in a cecectomized rat model. by Rahsan Erdem (11726357)

Subjects:

Source data for Fig 3. by Rahsan Erdem (11726357)

Subjects:

Scatterplot of iOWH032 plasma concentrations versus diarrheal stool output rate. by Rahsan Erdem (11726357)

Subjects:

Reverse cumulative distribution plot for diarrheal stool output rate overall in the modified intent-to-treat population. by Rahsan Erdem (11726357)

Subjects: